![Hugh MacNaught](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Förmögenhet: 26 670 $ per 2026-08-31
Mr. Hugh MacNaught is a President, Chief Executive Officer & Director at VentriPoint Diagnostics Ltd. and a Chief Executive Officer at Nanologix Research, Inc. He is on the Board of Directors at VentriPoint Diagnostics Ltd. Mr. MacNaught was previously employed as an Executive Vice President by biOasis Technologies, Inc.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-07-08 | 375 634 ( 0,19 % ) | 26 670 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| VENTRIPOINT DIAGNOSTICS LTD. | Verkställande Direktör | 2024-02-05 |
Nanologix Research, Inc. | Verkställande Direktör | - |
| Företag | Position | Slut |
|---|---|---|
| VENTRIPOINT DIAGNOSTICS LTD. | Direktör/Styrelseledamot | 2020-10-01 |
| BIOASIS TECHNOLOGIES INC. | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
VentriPoint Diagnostics Ltd.
 VentriPoint Diagnostics Ltd. Medical SpecialtiesHealth Technology Manufactures cardiac imaging systems | Health Technology |
biOasis Technologies, Inc.
 biOasis Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic drug delivery for the treatment of neurological diseases and disorders | Health Technology |
Nanologix Research, Inc. |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
